![Stephen Connelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Connelly
Fondateur chez
EQUILLIUM, INC.
Fortune : 2 M $ au 30/06/2026
Profil
Stephen Connelly is the founder of Equillium, Inc., founded in 2017, where the title held is President & Chief Scientific Officer.
Former jobs include Director-Business Development at aTyr Pharma, Inc. from 2014 to 2016, Senior Scientist at The Scripps Research Institute from 2012 to 2014, and Principal at BioMed Ventures.
Education history includes undergraduate and doctorate degrees from The University of Exeter and an MBA from Rady School of Management at UC San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC. 1,21 % | 05/06/2026 | 762 025 ( 1,21 % ) | 2 M $ | 30/06/2026 |
Postes actifs de Stephen Connelly
| Sociétés | Poste | Début |
|---|---|---|
| EQUILLIUM, INC. | Fondateur | 16/03/2017 |
Anciens postes connus de Stephen Connelly
| Sociétés | Poste | Fin |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/03/2016 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/03/2014 |
BioMed Ventures
 BioMed Ventures Investment ManagersFinance BioMed Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in early stage transactions. | Corporate Officer/Principal | - |
Formation de Stephen Connelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Exeter
 The University of Exeter Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rady School of Management at UC San Diego
 Rady School of Management at UC San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMed Ventures
BioMed Ventures Investment ManagersFinance BioMed Ventures invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in early stage transactions. | Finance |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
